U.S. Food and Drug Administration
Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01)
Deadline
May 16, 2028
Eligibility
Global, Foreign organizations eligible, Kenya
Funding Amount
Unlock to view
Grant Overview
Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01) is a research funding opportunity offered by U.S. Food and Drug Administration covering areas such as Rare Diseases, Clinical Research, Therapeutics, Biomedical Research for applicants in Global, Foreign organizations eligible, Kenya. The application deadline is May 16, 2028.
Researchers, universities, institutions and eligible organizations should review the funder requirements, geographic eligibility, research focus and deadline before preparing an application.
Focus Areas
Geographic Eligibility
- •Global
- •Foreign organizations eligible
- •Kenya
Before You Apply
Confirm the final deadline, applicant requirements, funding conditions and submission instructions on the official funder website before submitting an application.